Radiotherapy & Oncology
Издатель: Elsevier · ISSN 0167-8140 · 68 статей
- Stereotactic ablative radiotherapy for oligometastatic breast cancer: A systematic review and meta-analysis (SABRINA)
- Predictors of radiation-induced lymphopenia in NSCLC: blood and bone marrow dose during chemoradiotherapy
- Low-dose, high hopes? The potential of radiation therapy in Alzheimer’s disease
- How to plan and deliver lung cancer reirradiation: A consensus approach from the ESTRO reirradiation and lung focus groups and ReCOG
- QART or SMART? Expanding quality assurance into the safe Management, assurance and reporting of radiotherapy techniques
- Dosimetric impact of CBCT-guided online adaptive stereotactic body radiotherapy for prostate cancer: a 250-fraction retrospective analysis
- Impact of sexological follow-up on the sexual function of patients treated with chemo-radiotherapy and brachytherapy for locally advanced cervical cancer: results of the prospective FEMINICOL study
- Is it tumor burden? A critical analysis of postirradiation lymphopenia in lung cancer patients
- Prognostic value of lymph node ratio beyond extranodal extension in node-positive oral cavity squamous cell carcinoma
- Navigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting
- Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer
- Bioabsorbable spacer-assisted high-dose proton beam therapy for unresectable locally advanced pancreatic cancer of the body or tail: a feasibility and safety study
- Independent validation of a predictive risk model for contrast-enhancing brain lesions supports enhanced periventricular radiosensitivity and variable proton RBE
- Aims+Scope/Editorial Board/ Publication information
- Contents
- Safety of combining radiation therapy and antibody-drug conjugates in patients with breast cancer: a systematic review and meta-analysis
- Dose rate matters: comparative outcomes of high and low dose rate LINAC stereotactic radiosurgery in trigeminal neuralgia
- Early target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial
- Lessons learned from the multicentre QA program in SBRT for perihilar cholangiocarcinoma: benchmark-case results from the STRONG II trial
- Impact of accumulated target dose on tumor response in distal esophageal cancer treated with intensity-modulated proton therapy
- Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study
- Initial complete local therapy without systemic therapy versus systemic-therapy-based management in selected patients with oligometastatic renal cell carcinoma: a matched comparative study
- De-escalating elective nodal irradiation dose to 45 Gy in nasopharyngeal carcinoma: A large-cohort study with 5-year outcomes
- Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy
- Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study
- Population-based analysis of single-fraction versus multi-fraction stereotactic ablative radiotherapy for early-stage non-small cell lung cancer
- Influence of dosimetry on outcomes in HDR prostate brachytherapy monotherapy
- Technical and biological validation of prostate apparent diffusion coefficient measurements on an MRI-linac
- From patient-reported outcome scores to clinical meaning: defining thresholds for clinical importance for the EORTC QLQ-PR25 questionnaire for patients with prostate cancer
- Dosimetric correlation of radiation-induced chronic kidney disease (CKD): a competing risks analysis